Christopher Haydek, MD
Gastroenterology · Castle Rock, CONPI 1164963336
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $105,025 of the $111,535 with a category attached, or 94.2%. Capsovision, Inc. accounts for 94.2% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $107,740, more than ten times the $923 reported in 2023. Among gastroenterology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 288 payments — averaging $387.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Capsovision, Inc.$105K
- AbbVie$2K
- Johnson & Johnson$627
- Takeda Pharmaceuticals U.S.A., Inc.$602
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$531
- Sanofi$512
- plus $3K from 22 others
What the payments were for
- Consulting fees$105,02594%
- Food & beverage$6,4426%
- Education$690%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Capsovision, Inc. | 8 | $105,025 |
| AbbVie | 66 | $1,590 |
| Johnson & Johnson | 30 | $627 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $602 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $531 |
| Sanofi | 19 | $512 |
| Lilly USA, LLC | 14 | $409 |
| Pfizer | 17 | $277 |
| Gilead | 13 | $255 |
| QOL Medical, LLC | 11 | $244 |
| Ardelyx, Inc. | 9 | $222 |
| Regeneron Healthcare Solutions, Inc. | 8 | $190 |
| Phathom Pharmaceuticals, Inc. | 7 | $179 |
| Ipsen Biopharmaceuticals, Inc | 4 | $113 |
| Ferring Pharmaceuticals Inc. | 5 | $104 |
| Bristol Myers Squibb | 5 | $95 |
| Intercept Pharmaceuticals, Inc. | 5 | $91 |
| Amgen | 3 | $70 |
| Madrigal Pharmaceuticals | 3 | $65 |
| Celltrion USA Inc. | 2 | $53 |
| Laborie Medical Technologies Corp. | 1 | $42 |
| Aimmune Therapeutics, Inc. | 2 | $41 |
| Merck | 2 | $41 |
| Ironwood Pharmaceuticals, Inc | 2 | $40 |
| Organon | 2 | $39 |
| Lucid Diagnostics Inc. | 1 | $32 |
| Medtronic | 1 | $27 |
| Novo Nordisk | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CapsoCam Plus$101,880
- CapsoCam Colon$3,145
- Skyrizi$382
- Entyvio$135
- Rinvoq$125
- OMVOH$123
How this compares
$111,535 in reported general payments places this provider in the 95th percentile of 304 gastroenterology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 17 | $40,649 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 68 | $11,068 |
| Omeprazole | 148 | $3,299 |
| SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag | 19 | $2,419 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 14 | $1,148 |
| Esomeprazole Magnesium | 11 | $378 |
| Famotidine | 14 | $108 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon | $1,590 | $40,64917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 304 gastroenterology providers in Colorado.
Other gastroenterology in Castle Rock
- Peter leCastle Rock$138K
- Lisa MathewCastle Rock$10K
- Peter McNallyFt Carson$1.1M
- Douglas AdlerColorado Springs$910K
- Marcelo KugelmasEnglewood$660K
- Mary Ann HuangDenver$408K
- Gareth WeinerThornton$382K
- Matthew NicholsLone Tree$360K
- Nathan SchomakerLone Tree$344K
- Joshua SteinbergNorthglenn$266K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.